View Featured Related Documents View all Featured
After a 12-year hiatus, military recruit training centers resumed administration of adenovirus type 4 and type 7 vaccine, live, oral (adenovirus vaccine) to trainees beginning in October of 2011. Subsequently, rates of febrile respiratory illnesses (FRI) and adenovirus isolations markedly declined. These findings are consistent with those of a placebo-controlled efficacy trial conducted prior to the vaccine’s licensure by the FDA.  Continued surveillance will clarify the longer term impact of vaccine use.
By integrating our two organizations, we're expanding everything from education and training, to regional support operations, to vaccine policy and program management, said LTC Jorge Carrillo, acting director MILVAX-VHCN. It also allows for an expanded and dedicated staff to focus on research and enhancing scientific understanding of vaccine safety and effectiveness.
South Dakota Medicine recently published its 2013 special edition, The Story of Immunization. The edition is devoted to an exploration of the safety and efficacy of vaccines and their importance in relation to public health. It includes articles on the history of vaccines, the science of vaccination, outbreaks, and much more.
The VERP captures the unique causes and consequences of vaccine related errors. All information is confidential and in addition is shared with the CDC and FDA. The ISMP VERP is highly recommended for all locations without access to the DoD Patient Safety Reporting (PSR) System.
CDC guidance on completing the recommended pediatric immunizations schedule during the shortage of Pentacel and Daptacel. The shortage is expected to last through summer 2012
Guidance for Vaccinating Children during 2012 Pentacel/Daptacel Shortage
This web-on-demand program, offered by the CDC, is a comprehensive overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them.
CDC 2012 Epidemiology & Prevention of Vaccine-Preventable Diseases; On-Demand Web Training
A primer by the American Academy of Microbiology to understanding how vaccines work and why they are important, but there is much more to learn. The best information on vaccination comes from the experts studying them. If you would like to learn more about vaccines you can turn to any of the sources listed in this report.  They will provide reliable information, checked by scientists and researchers for accuracy.
Adult Vaccines: A Grown Up Thing to Do
There were no new serious vaccine safety concerns following TIV-HD identified in VAERS during the first year after licensure. Findings were consistent with conditions found from pre-licensure studies (e.g., fever and pain) that were more frequently reported after TIV-HD than after receipt of standard dose TIV.
Postlicensure Safety Surveillance for TIV-HD in VAERS
This FDA study is important because it provides additional scientific information confirming that the benefits of aluminum-containing vaccines administered during the first year of life outweigh any theoretical concerns about the potential effect of aluminum on infants.
Study Reports Aluminum in Vaccines Poses Extremely Low Risk to Infants
Quadrivalent Human Papillomavirus Vaccine Initiation, Coverage, and Compliance Among U.S. Active Component Service Women, 2006-2011 -  Consistent with ACIP recommendations, the DoD has made the HPV4 vaccine available to all eligible service members aged 17–26 years. Despite vaccine availability, utilization of the HPV4 vaccine by active component U.S. service women has been reported to be low.
AAP recommends immunization against human papillomavirus (HPV) for all 11- through 12-year-old children as part of the adolescent immunization program.
Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists 2014-2015 Influenza Season Week 9 ending March 7, 2015.
Each week the Armed Forces Health Surveillance Center publishes a summary of influenza activity in the COCOMS. The summary tracks influenza like illness, flu activity through the DoD laboratory surveillance network and influenza vaccination coverage. Reports are by COCOM and service members or beneficiary populations.
On November 20th the FDA announced approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs. Flucelvax is approved to prevent seasonal influenza in people ages 18 years and older. The manufacturing process is similar to the egg-based production method, but a significant difference is that the virus strains included in the vaccine are grown in animal cells of mammalian origin instead of in eggs. Cell culture technology has already been in use for several decades to produce other U.S. licensed vaccines.
In 2000 the US achieved measles elimination however, importation of measles continues and  in 2011 the US reported 222 measles cases and 17 outbreaks. 90% of cases reported last year were associated with importation from other countries.
In August 2011, a male U.S. Army soldier with progressive right arm and shoulder pain, nausea, vomiting, ataxia, anxiety, and dysphagia was admitted to an emergency department (ED) in New York for suspected rabies. Rabies virus antigens were detected in a nuchal skin biopsy, rabies virus antibodies in serum and cerebrospinal fluid (CSF), and rabies viral RNA in saliva and CSF specimens by state and CDC rabies laboratories. An Afghanistan canine rabies virus variant was identified.
A case review of myopericarditis in service members following vaccination with the smallpox vaccine.